AKT1 and thyroid gland carcinoma: IGF/IGFR signaling pathway contributes to tumorigenesis and also drug resistance in thyroid cancer via activation of PI3K/AKT signaling pathway, leading to the expression of pro‐survival genes and increased cell proliferation.